John Vinh Pham, DO
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Indian Health Center of Santa Clara Valley · 37 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Pham’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Medicaid work
$232,256 in 2024
Medicaid paid $232,256 for 2,563 billed services this clinician did in 2024, up to 102 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 943 | $210,773 |
| Short return visit (20+ min) | 1,602 | $21,386 |
| Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 18 | $97 |
| 2024 | 2,563 | 3 | 102 | $232,256 |
| 2023 | 3,056 | 3 | 117 | $257,878 |
| 2022 | 2,455 | 4 | 108 | $238,632 |
| 2021 | 4,648 | 11 | 161 | $259,157 |
| 2020 | 3,001 | 6 | 111 | $171,913 |
| 2019 | 891 | 6 | 75 | $40,982 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,131 | $251,298 |
| Short return visit (20+ min) | 1,873 | $6,540 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 52 | $40 |
2022
| Clinic visit/encounter, all-inclusive | 1,036 | $238,270 |
| Short return visit (20+ min) | 1,187 | $342 |
| Short return visit | 200 | $20 |
| Return visit (30+ min) | 32 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 1,773 | $259,157 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 114 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure) | 12 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 31 | $0 |
| Screening test, pure tone, air only | 89 | $0 |
| Bilateral quantitative screening test of visual acuity | 85 | $0 |
| New patient visit (30+ min) | 240 | $0 |
| New patient visit (45+ min) | 12 | $0 |
| Short return visit | 50 | $0 |
| Short return visit (20+ min) | 2,194 | $0 |
| Return visit (30+ min) | 48 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 1,196 | $171,913 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 23 | $0 |
| New patient visit (30+ min) | 176 | $0 |
| Short return visit | 45 | $0 |
| Short return visit (20+ min) | 1,493 | $0 |
| Return visit (30+ min) | 68 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 287 | $40,982 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 44 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 16 | $0 |
| New patient visit (30+ min) | 116 | $0 |
| Short return visit (20+ min) | 410 | $0 |
| Return visit (30+ min) | 18 | $0 |
Drugs they prescribed that Part D paid
$201,768
Pharmacies billed $201,768 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (13 of 1,453) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
1,235 generic and 205 brand-name prescriptions · $201,768 in drug cost · 15 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Trulicity | 44 | $40,980 | $931 |
| Jardiance | 23 | $26,121 | $1,136 |
| Ozempic | 16 | $23,712 | $1,482 |
| Eliquis | 18 | $17,863 | $992 |
| Atorvastatin | 128 | $853 | $7 |
See all 33 drugs
| Trulicity | 44 | $40,980 | $931 |
| Jardiance | 23 | $26,121 | $1,136 |
| Ozempic | 16 | $23,712 | $1,482 |
| Eliquis | 18 | $17,863 | $992 |
| Atorvastatin | 128 | $853 | $7 |
| Diclofenac | 26 | $788 | $30 |
| Triamcinolone Acetonide | 23 | $734 | $32 |
| Albuterol Sulfate Hfa | 22 | $710 | $32 |
| Clindamycin Phosphate | 12 | $709 | $59 |
| Gabapentin | 21 | $597 | $28 |
| Metoprolol | 27 | $409 | $15 |
| Omeprazole | 35 | $394 | $11 |
| Amlodipine Besylate | 94 | $371 | $4 |
| Metformin | 66 | $343 | $5 |
| Trazodone | 40 | $316 | $8 |
| Divalproex | 12 | $296 | $25 |
| Losartan | 56 | $248 | $4 |
| Fluticasone Propionate | 15 | $206 | $14 |
| Levothyroxine | 18 | $199 | $11 |
| Tamsulosin | 23 | $193 | $8 |
| Famotidine | 19 | $193 | $10 |
| Carvedilol | 23 | $188 | $8 |
| Alprazolam | 18 | $188 | $10 |
| Lisinopril | 43 | $184 | $4 |
| Glipizide | 30 | $168 | $6 |
| Hydrochlorothiazide | 34 | $151 | $4 |
| Pravastatin | 13 | $115 | $9 |
| Pantoprazole | 15 | $94 | $6 |
| Montelukast | 31 | $89 | $3 |
| Benazepril | 14 | $65 | $5 |
| Metoprolol | 19 | $56 | $3 |
| Lovastatin | 12 | $48 | $4 |
| Furosemide | 16 | $43 | $3 |
Year by year
| 2024 | 1,453 | 149 | 1% (13) | 14% | $201,768 |
| 2023 | 1,483 | 213 | 2% (24) | None | $229,263 |
| 2022 | 1,040 | 212 | 1% (14) | None | $86,633 |
| 2021 | 1,060 | 165 | None | None | $31,373 |
| 2020 | 956 | 149 | None | None | $36,791 |
| 2019 | 177 | 73 | None | None | $8,633 |
| 2018 | 540 | 101 | None | None | $32,872 |
| 2017 | 466 | 127 | 3% (14) | None | $38,870 |
| 2016 | 128 | 49 | None | 24% | $7,729 |
| 2015 | 25 | None | None | None | $297 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 38 drugs
| Rybelsus | 19 | $37,330 | $1,965 |
| Jardiance | 24 | $32,725 | $1,364 |
| Trulicity | 19 | $23,950 | $1,261 |
| Januvia | 11 | $18,230 | $1,657 |
| Eliquis | 23 | $15,708 | $683 |
| Atorvastatin | 109 | $2,259 | $21 |
| Amlodipine Besylate | 100 | $1,355 | $14 |
| Losartan | 67 | $1,247 | $19 |
| Metformin | 57 | $1,170 | $21 |
| Tamsulosin | 34 | $1,156 | $34 |
| Gabapentin | 46 | $987 | $21 |
| Ventolin Hfa | 11 | $926 | $84 |
| Omeprazole | 42 | $854 | $20 |
| Rosuvastatin | 16 | $810 | $51 |
| Diclofenac | 27 | $809 | $30 |
| Clindamycin Phosphate | 12 | $768 | $64 |
| Metoprolol | 20 | $625 | $31 |
| Albuterol Sulfate Hfa | 13 | $572 | $44 |
| Fluticasone Propionate | 28 | $495 | $18 |
| Oxycodone-Acetaminophen | 11 | $468 | $43 |
| Levothyroxine | 19 | $460 | $24 |
| Benazepril | 15 | $452 | $30 |
| Montelukast | 32 | $443 | $14 |
| Famotidine | 13 | $399 | $31 |
| Furosemide | 34 | $320 | $9 |
| Triamcinolone Acetonide | 18 | $300 | $17 |
| Metoprolol | 20 | $294 | $15 |
| Lisinopril | 41 | $284 | $7 |
| Glipizide | 17 | $270 | $16 |
| Pravastatin | 11 | $256 | $23 |
| Trazodone | 21 | $256 | $12 |
| Cromolyn | 11 | $189 | $17 |
| Carvedilol | 20 | $186 | $9 |
| Pantoprazole | 16 | $186 | $12 |
| Finasteride | 11 | $163 | $15 |
| Hydrochlorothiazide | 21 | $154 | $7 |
| Lisinopril-Hydrochlorothiazide | 13 | $120 | $9 |
| Naproxen | 12 | $84 | $7 |
2022: 22 drugs
| Jardiance | 19 | $26,666 | $1,403 |
| Gabapentin | 62 | $1,133 | $18 |
| Albuterol Sulfate Hfa | 13 | $930 | $72 |
| Atorvastatin | 69 | $901 | $13 |
| Amlodipine Besylate | 108 | $855 | $8 |
| Ketoconazole | 15 | $777 | $52 |
| Omeprazole | 45 | $739 | $16 |
| Levocetirizine Dihydrochloride | 11 | $627 | $57 |
| Metformin | 45 | $398 | $9 |
| Losartan | 37 | $378 | $10 |
| Lisinopril | 39 | $323 | $8 |
| Diclofenac | 18 | $305 | $17 |
| Baclofen | 17 | $288 | $17 |
| Metoprolol | 24 | $275 | $11 |
| Famotidine | 15 | $224 | $15 |
| Pantoprazole | 15 | $218 | $15 |
| Fluticasone Propionate | 19 | $215 | $11 |
| Tamsulosin | 20 | $211 | $11 |
| Furosemide | 31 | $203 | $7 |
| Levothyroxine | 12 | $198 | $16 |
| Cyclobenzaprine | 11 | $195 | $18 |
| Ibuprofen | 17 | $63 | $4 |
2021: 28 drugs
| Atorvastatin | 88 | $1,120 | $13 |
| Gabapentin | 64 | $984 | $15 |
| Amlodipine Besylate | 92 | $706 | $8 |
| Levothyroxine | 40 | $652 | $16 |
| Albuterol Sulfate Hfa | 12 | $520 | $43 |
| Losartan | 40 | $403 | $10 |
| Metoprolol | 30 | $398 | $13 |
| Triamcinolone Acetonide | 21 | $369 | $18 |
| Metformin | 59 | $357 | $6 |
| Baclofen | 16 | $333 | $21 |
| Tamsulosin | 25 | $323 | $13 |
| Omeprazole | 22 | $264 | $12 |
| Donepezil | 12 | $247 | $21 |
| Finasteride | 13 | $243 | $19 |
| Allopurinol | 14 | $223 | $16 |
| Fluticasone Propionate | 15 | $212 | $14 |
| Metoprolol | 29 | $197 | $7 |
| Furosemide | 21 | $190 | $9 |
| Lisinopril | 24 | $181 | $8 |
| Fosinopril | 12 | $172 | $14 |
| Simvastatin | 23 | $147 | $6 |
| Zolpidem | 11 | $133 | $12 |
| Metformin Hcl Er | 12 | $117 | $10 |
| Glipizide | 13 | $109 | $8 |
| Atenolol | 18 | $96 | $5 |
| Mupirocin | 14 | $80 | $6 |
| Hydrochlorothiazide | 11 | $79 | $7 |
| Ibuprofen | 21 | $62 | $3 |
2020: 21 drugs
| Lantus | 11 | $2,951 | $268 |
| Levothyroxine | 49 | $761 | $16 |
| Atorvastatin | 71 | $694 | $10 |
| Gabapentin | 47 | $629 | $13 |
| Amlodipine Besylate | 96 | $500 | $5 |
| Losartan | 40 | $488 | $12 |
| Metoprolol | 20 | $324 | $16 |
| Omeprazole | 27 | $239 | $9 |
| Metformin | 36 | $232 | $6 |
| Fluticasone Propionate | 15 | $192 | $13 |
| Trazodone | 12 | $168 | $14 |
| Hydrochlorothiazide | 18 | $159 | $9 |
| Tamsulosin | 17 | $155 | $9 |
| Allopurinol | 13 | $136 | $10 |
| Simvastatin | 28 | $124 | $4 |
| Lisinopril | 23 | $124 | $5 |
| Clopidogrel | 11 | $88 | $8 |
| Metoprolol | 15 | $87 | $6 |
| Glipizide | 11 | $74 | $7 |
| Meloxicam | 17 | $58 | $3 |
| Furosemide | 17 | $49 | $3 |
2019: 1 drug
| Losartan | 16 | $99 | $6 |
2018: 12 drugs
| Advair Diskus | 15 | $5,935 | $396 |
| Omeprazole | 20 | $316 | $16 |
| Gabapentin | 19 | $306 | $16 |
| Rosuvastatin | 13 | $306 | $24 |
| Montelukast | 14 | $209 | $15 |
| Pantoprazole | 21 | $180 | $9 |
| Atorvastatin | 12 | $163 | $14 |
| Simvastatin | 25 | $142 | $6 |
| Sertraline | 17 | $142 | $8 |
| Lisinopril | 35 | $129 | $4 |
| Metformin | 15 | $98 | $7 |
| Amlodipine Besylate | 12 | $95 | $8 |
2017: 13 drugs
| Spiriva | 11 | $4,189 | $381 |
| Advair Diskus | 11 | $3,992 | $363 |
| Gabapentin | 18 | $366 | $20 |
| Doxycycline Hyclate | 11 | $298 | $27 |
| Levothyroxine | 11 | $263 | $24 |
| Omeprazole | 17 | $232 | $14 |
| Amlodipine Besylate | 20 | $168 | $8 |
| Metoprolol | 14 | $92 | $7 |
| Pioglitazone | 11 | $80 | $7 |
| Losartan | 13 | $71 | $5 |
| Tramadol | 12 | $62 | $5 |
| Lisinopril | 21 | $57 | $3 |
| Prednisone | 18 | $52 | $3 |
Money from drug and device companies
$21 in 2024
| 2024 | 1 | 1 | None | $21 |
| 2022 | 1 | 1 | None | $13 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alkermes | Aristada | $21 | 1 payment
|
See the published payment
| Alkermes | Meals · 2024-09-17 | Aristada | $21 |
See earlier years (2022)
2022: $13
| GlaxoSmithKline | Trelegy Ellipta | $13 | 1 payment
|
Professional record
- NPI
- 1326421827
- Licence
- CA 20A17004
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 1642 E Capitol Expy, San Jose, CA, 95121
- NPI first listed
- 2015-07-01
- NPI last updated
- 2025-06-05
- NPI record certified
- 2025-06-05
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1333 Meridian Ave, San Jose, CA, 95125 · 2039 Forest Ave Ste 105, San Jose, CA, 95128 · 455 Oconnor Dr, San Jose, CA, 95128